Loading organizations...
§ Venture Capital · Avenue Alexandre 8, 1330 Rixensart
Vinsovier operates as a private investment vehicle, providing capital and strategic guidance to promising companies across diverse sectors. It focuses on enterprises with strong growth potential, particularly in biotechnology and technology, fostering their development through informed investment and active support. The firm aims to accelerate innovation and enhance its portfolio companies' market presence.
The entity was established by Jean Stéphenne, a distinguished figure recognized for significant achievements in the pharmaceutical industry. His extensive career and desire to contribute to the innovation ecosystem led to Vinsovier’s formation, conceived as a platform to channel strategic insights and capital into emerging ventures, effectively supporting next-generation companies.
Vinsovier primarily partners with growth-stage companies seeking both financial backing and seasoned mentorship. Its portfolio includes entities like OncoDNA, contributing to advancements in precision oncology. The firm's vision is to identify and empower disruptive technologies and business models, driving progress in key industries and generating sustainable value.
Vinsovier has 1 tracked investment across 1 company. The latest tracked deal is $8.6M Other Equity in OncoDNA in September 2016.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 4, 2016 | OncoDNA | $8.6M Other Equity | — | Crown Predator Holdings, Inventures, Invest4OncoDNA, Ipg/bio.be, Sambrinvest, Sofinim, Sriw |